The Blood Test That Tells You If Your Newborn Has A Virus Or Serious Infection (And Saves You From Unnecessary Antibiotics)
This new method helps parents and doctors see the difference between serious bacterial illness and a mild virus
Think of your pantry. You would not dump in a handful of salt just to see if a soup cooks. You measure. You taste. You know exactly what flavor profile you are aiming for. Medicine is a bit like that. You want the right ingredients for the right job. When it comes to a baby with a fever, the ingredients are tricky. A fever in a baby younger than 3 months is considered a medical emergency. Why? Because an infection can quickly become life-threatening in a very young baby whose immune system is still developing. In the emergency department, staff need to assess babies with fever to distinguish serious bacterial infections that require antibiotics from viral infections that typically pass with monitoring and care.
A test that compares the levels of two molecules in the blood can accurately distinguish between bacterial and viral infections in newborn babies with fever, according to a small study presented at the European Emergency Medicine Congress. The research was presented by Dr. Tommaso Bellini, a pediatric emergency physician at the IRCCS Istituto Giannina Gaslini in Genoa, Italy. He said, "In very young babies with fever, distinguishing serious bacterial infection from self-limiting viral illness is a major diagnostic dilemma." Our standard biomarkers can help show when there might be a bacterial infection, but they also create 'false positives,' which drives overtreatment. This can mean unnecessary lumbar punctures, antibiotics and hospital admissions for infants who turn out to have only a virus.
The research involved 60 babies who were brought to the pediatric emergency department of IRCCS Istituto Giannina Gaslini. Some were being assessed and treated for fever, while others were being assessed and treated for other, noninfectious conditions. Bellini and his colleagues collected blood samples from all the babies. They tested the samples with flow cytometry, which is an advanced technique that allows researchers to study the characteristics of individual cells. They used this technique to measure the levels of two molecules known to increase in response to infections. One is called CD64. It is found on the surface of neutrophils, a type of white blood cell. It is thought to increase in response to bacterial infection. The other is CD169. It is found on the surface of another type of white blood cell called a monocyte. It is thought to increase in response to a viral infection.
The researchers combined measurements of both molecules into a ratio for each baby. The ratio is a simple way of comparing the amount of one thing with the amount of another. They found that this ratio could accurately distinguish between babies with no infection, babies who were ultimately confirmed to have a viral infection, and babies confirmed to have a bacterial infection. The test had a "sensitivity" of 100 percent. This means it correctly picked up all the cases of bacterial infection. It had a "specificity" of 96.6 percent. This means the rate of "false positives" was extremely low. The scores were distinct. There was an average ratio score of 1.10 for babies with no infection, 0.33 for viral infection, and 16.22 for bacterial infection.
For parents, taking a very young baby with a fever into the emergency department can be a very worrying time. We have to treat every case as potentially serious until we know otherwise. At the moment, this can mean invasive tests, treatment with antibiotics and spending a long time in the hospital. Dr. Maša Sorić is a member of the EUSEM abstract selection committee. She is head of the emergency department at University Hospital Merkur in Zagreb, Croatia. She was not involved with the research. She said, "This is a small study, but the findings are very positive. If these results can be reinforced in a larger trial, they could mean that we have a much better way of knowing which babies probably have a bacterial infection that needs antibiotics, and which babies probably do not." This could ultimately improve treatment and reduce the need for unnecessary treatment.
There is also a broader issue with bacteria becoming resistant to antibiotics, partly as a result of overuse of these treatments. If we can ensure we only use antibiotics when they are needed, we may also reduce the growth of antibiotic resistance, helping to maintain the effectiveness of these vital medicines. Bellini said, "These two marker molecules show opposite signatures, during a viral infection one is high while the other is low, and during a bacterial infection the reverse is true." Combining them into a single ratio separated bacterial from nonbacterial infection with very high accuracy in our initial cohort of 60 babies. This assessment is currently run on flow cytometry, which needs specialized equipment and trained staff. It is not yet a bedside test and is not widely available outside of specialist labs. Translating it into a fast, low-cost, point-of-care format is our next research goal.
The research is continuing and will ultimately include data on 75 babies. Bellini and his colleagues are also beginning a larger study called DISCERN. DISCERN stands for Discriminating Infection via Surface CD-marker Expression Ratios iN infancy. This is a multicenter, prospective study assessing the accuracy of the test in 300 to 500 babies. This expansion is crucial. It moves the science from a small kitchen experiment to a full restaurant menu. It will verify that the CD64 and CD169 ratio works not just in Genoa but in different kitchens around the world.
First reported by Medical Xpress.
More in Health & Nutrition
- Long-term opioid use fails to alleviate chronic back pain, Northwestern University study suggests
Researchers identified distinct brain activity patterns and molecular markers that may guide future treatments for pain management and opioid tapering.
- Human tau seeds trigger disease-specific shapes in mouse brains, new study finds
Study in Nature shows that injectable human tau aggregates from Alzheimer’s and corticobasal degeneration template their 3D folds onto mouse tau, supporting the prion-like seeding model.
- Menopause Largely Missing from Electronic Health Records Despite Its Health Impact
study of nearly 240,000 women finds only 12% of electronic records include menopause status, even though over half reported being in transition.